Nateglinide: a Double Blind Add-on Study With Pioglitazone for Type 2 Diabetic Patients
Clinical trial NCT00189774 · COMPLETED
Trial details
- NCT number
- NCT00189774
- Sponsor
- Astellas Pharma Inc
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.